Produits et services

Plant extracts used as ingredients for nutritional supplements for dietary and health applications; dietetic foods, beverages and substances adapted for medical use; nutritional additives for medical purposes; medical and pharmaceutical preparations.

Produits et services

Plant extracts used as ingredients for nutritional supplements for dietary and health applications; dietetic foods, beverages and substances adapted for medical use; nutritional additives for medical purposes; medical and pharmaceutical preparations

Abrégé

The present invention relates to an oral composition of Withania extract as or its salts and/or in combination with total Withanolides comprising Withanolide Glycosides (Withanoside IV and Withanoside V/VI) and Withanolide aglycones (Withanolide A, Withanolide B, Withaferin-A and 12- deoxy withastramonolide) and/or its salts. The present invention is also related to the process of preparation of the oral composition Withania somnifera and at least one pharmaceutically and/or nutraceutically acceptable excipients for prevention, improvement, and maintenance of cognitive health to a subject in need thereof. The invention also discloses the process for preparing extracts from plant parts of Withania somnifera. The composition of the present invention is available in dosage forms like powder, beadlets, granules, capsules, tablets, oil suspension, films or any other suitable oral or topical dosage forms used for prevention, improvement and maintenance of cognitive health.

Classes IPC  ?

• A61K 36/81 - Solanaceae (famille de la pomme de terre), p. ex. tabac, Solanum ptycanthum, tomate, belladone, poivron ou datura
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 31/58 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes contenant des hétérocycles, p. ex. danazol, stanozolol, pancuronium ou digitogénine
• A61K 31/702 - Oligosaccharides, c.-à-d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
• A61K 47/36 - PolysaccharidesLeurs dérivés, p. ex. gommes, amidon, alginate, dextrine, acide hyaluronique, chitosane, inuline, agar-agar ou pectine
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes

Abrégé

The present invention relates to an oral berberis extract composition and the process for the preparation of the composition of berberis extract as whole or its salts and/or in combination with berberine, jatrorrhizine, and columbamine or its salts with at least one pharmaceutically and/or nutraceutically accepted excipients for prevention, improvement, and maintenance of cognitive health to a subject in need thereof. Further encompassing to the oral berberis composition wherein the berberis extract is comprised of berberis extract as whole or its salts and/or in combination with berberine and/or its salt, and optionally jatrorrhizine, and columbamine or its salts in different forms like powder, beadlets, granules, capsules, tablets, oil suspension, films or any other suitable oral or topical dosage forms. A method of use of the berberis extract composition for prevention, improvement, and maintenance of cognitive health.

Classes IPC  ?

• A61K 36/29 - Berberidaceae (famille l'épine-vinette), p. ex. épine-vinette, cohosh ou podophyllum
• A61K 31/015 - Hydrocarbures carbocycliques
• A61K 31/14 - Composés d'ammonium quaternaire, p. ex. édrophonium, choline
• A61K 31/355 - Tocophérols, p. ex. vitamine E
• A61K 31/4525 - Pipéridines non condensées, p. ex. pipérocaïne contenant d'autres systèmes hétérocycliques contenant un cycle à cinq chaînons avec l'oxygène comme hétéro-atome du cycle
• A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
• A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence

Produits et services

Plant extract used as a component ingredient of dietary supplements and nutritional supplements; Nutritional and dietary supplements.

Produits et services

(1) Nutritional supplements, namely, for eye health, comfort and hydration

Produits et services

Food grade excipients, antioxidants, and plant extracts, other than essential oils, used in the manufacture of nutritional and dietary supplements.

Abrégé

The present invention relates to an oral berberis extract composition and the process for the preparation of the composition of berberis extract as whole or its salts and/or in combination with berberine, jatrorrhizine, and columbamine or its salts with at least one pharmaceutically and/or nutraceutically accepted excipients for prevention, improvement, and maintenance of cognitive health to a subject in need thereof. Further encompassing to the oral berberis composition wherein the berberis extract is comprised of berberis extract as whole or its salts and/or in combination with berberine and/or its salt, and optionally jatrorrhizine, and columbamine or its salts in different forms like powder, beadlets, granules, capsules, tablets, oil suspension, films or any other suitable oral or topical dosage forms. A method of use of the berberis extract composition for prevention, improvement, and maintenance of cognitive health.

Classes IPC  ?

• A61K 36/29 - Berberidaceae (famille l'épine-vinette), p. ex. épine-vinette, cohosh ou podophyllum
• A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
• A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
• A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
• A23L 33/24 - Cellulose ou ses dérivés
• A23L 33/21 - Adjonction de substances essentiellement non digestibles, p. ex. de fibres diététiques

Abrégé

The present invention relates to a xanthophyll composition comprising selective isomers of trans-R,R lutein and trans-R,R zeaxanthin in preferred particle size and pharmaceutically and/or nutraceutically acceptable excipients such as carriers, solubility enhancers, bioavailability enhancing agents, antioxidants and optionally flavoring agents with selective ratio which exerts enhanced bioavailability. The xanthophyll composition at least 80% of total xanthophyll comprised of at least 65% by weight of trans-R,R lutein and at least 10% by weight of trans-R,R zeaxanthin, which is prepared combinedly from marigold and paprika oleoresins with definite proportion to produce the preferred ratio of trans-R,R lutein and trans-R,R zeaxanthin.

Classes IPC  ?

• A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol
• A61K 47/44 - Huiles, graisses ou cires couvertes par plus d’un des groupes Huiles, graisses ou cires naturelles ou naturelles modifiées, p. ex. huile de ricin, huile de ricin polyéthoxylée, cire de lignite, lignite, gomme-laque, colophane, cire d’abeille ou lanoline
• A61K 9/107 - Émulsions

Abrégé

The present invention relates to a stable curcumin composition for prevention improvement and maintenance of arthritis more particularly to osteoarthritis. The stable curcumin composition is comprised of curcuminoids either alone or along with at least one pharmaceutically and/or nutraceutically accepted excipient to form the stable curcumin compositions having enhancement in absorption and bioavailability. The composition is safe for consumption, possess enhanced stability and bioavailability due to selective percentage of amorphous and crystalline polymorphic form of curcumin along with selective excipient such as pH modifier and/or stabilizer and optionally hydrophilic carrier, antioxidant, diluents, anticaking agent, emulsifier, fat and surfactant which result in improvement of symptoms of arthritis and associated conditions, when administered to subjects, in need thereof.

Classes IPC  ?

• A61K 31/12 - Cétones
• A61P 19/02 - Médicaments pour le traitement des troubles du squelette des troubles articulaires, p. ex. arthrites, arthroses
• A61K 47/38 - CelluloseSes dérivés
• A61K 47/24 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite contenant des atomes autres que des atomes de carbone, d'hydrogène, d'oxygène, d'halogènes, d'azote ou de soufre, p. ex. cyclométhicone ou phospholipides
• A61K 47/14 - Esters d’acides carboxyliques, p. ex. acides gras monoglycérides, triglycérides à chaine moyenne, parabènes ou esters d’acide gras de PEG
• A61K 47/22 - Composés hétérocycliques, p. ex. acide ascorbique, tocophérol ou pyrrolidones
• A61K 47/20 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite contenant du soufre, p. ex. sulfoxyde de diméthyle [DMSO], docusate, laurylsulfate de sodium ou acides aminosulfoniques
• A61K 47/12 - Acides carboxyliquesLeurs sels ou anhydrides
• A61K 47/06 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite

Abrégé

The present invention is related to the valerian composition and /or valerian extract for prevention, improvement, and maintenance of sleep disorders and/or sleep management per se improve the quality sleep, improves time to sleep, improves sleep duration, reduces sleep disturbances, maintain healthy stress levels to a subject in need thereof. A valerian composition comprising of the valerian extract and at least one pharmaceutically and/or nutraceutically accepted excipients. The present invention further encompasses the valerian composition wherein further formulated in different forms like powder, beadlets, granules, capsules, tablets, oil suspension, films or any other suitable oral or topical dosage forms using pharmaceutically and/or nutraceutically acceptable excipients.

Classes IPC  ?

• A61K 36/84 - Valerianaceae (famille de la valériane), p. ex. valériane
• A61P 25/20 - HypnotiquesSédatifs

Abrégé

The present invention is related to the valerian composition and /or valerian extract for prevention, improvement, and maintenance of sleep disorders and/or sleep management per se improve the quality sleep, improves time to sleep, improves sleep duration, reduces sleep disturbances, maintain healthy stress levels to a subject in need thereof. A valerian composition comprising of the valerian extract and at least one pharmaceutically and/or nutraceutically accepted excipients. The present invention further encompasses the valerian composition wherein further formulated in different forms like powder, beadlets, granules, capsules, tablets, oil suspension, films or any other suitable oral or topical dosage forms using pharmaceutically and/or nutraceutically acceptable excipients.

Classes IPC  ?

• A61K 36/84 - Valerianaceae (famille de la valériane), p. ex. valériane
• A61P 25/20 - HypnotiquesSédatifs

Abrégé

A nutritional composition for prevention, improvement and maintenance of visual function. The nutritional composition comprising the nutrients and at least one pharmaceutically and/or nutraceutically accepted excipient. The nutritional composition wherein the nutrients are selected from one or more of lutein, curcumin and vitamin D3 for prevention, improvement and maintenance of dry eye. The process of preparation of the nutritional composition comprising lutein, curcumin and vitamin D3 use for visual function more specifically dry eye. The present invention is further encompassing to the nutritional composition comprising lutein, curcumin, vitamin D3 in selective percentage which is formulated in different forms like as, powders, granules, pellets, beadlets, caplets, tablets, capsules, soft gel capsules, solution, emulsions, suspensions, oil suspensions, dispersions and the like.

Classes IPC  ?

• A61K 31/593 - Dérivés du 9,10-séco-cholestane, p. ex. cholécalciférol, vitamine D3
• A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol
• A61K 31/12 - Cétones
• A61K 47/44 - Huiles, graisses ou cires couvertes par plus d’un des groupes Huiles, graisses ou cires naturelles ou naturelles modifiées, p. ex. huile de ricin, huile de ricin polyéthoxylée, cire de lignite, lignite, gomme-laque, colophane, cire d’abeille ou lanoline
• A61K 47/24 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite contenant des atomes autres que des atomes de carbone, d'hydrogène, d'oxygène, d'halogènes, d'azote ou de soufre, p. ex. cyclométhicone ou phospholipides
• A61K 47/14 - Esters d’acides carboxyliques, p. ex. acides gras monoglycérides, triglycérides à chaine moyenne, parabènes ou esters d’acide gras de PEG
• A61P 27/04 - Larmes artificiellesSolutions d'irrigation

Produits et services

Plants extracts sold as an ingredient for or component part of nutritional and dietary supplements.

Produits et services

Plants extracts and nutraceuticals sold as an ingredient in or component part of nutritional and dietary supplements

Abrégé

The present invention describes pulsed release caffeine formulations comprising caffeine particulate systems prepared by using release retarding agents and at least one or more food grade excipients. The present invention also relates to the process for preparation of caffeine formulations, wherein plurality of particulate systems combined to get the pulsed release caffeine formulation comprising release retarding agents, which provide caffeine release in pulses at different physiological conditions. The pulsed release caffeine formulation is prepared as tablets, capsules, soft gel capsules, caplets, oil suspensions or mixed with nutrient supplements for administration to the subjects. Caffeine formulations as described herein release the caffeine over entire GIT in pulses in a period of 2 to 8 hours and can be administered to subjects for boosting energy, improving concentration, cardiovascular health and for weight management.

Classes IPC  ?

• A61K 9/50 - Microcapsules
• A23L 2/52 - Addition d'ingrédients
• A23F 3/14 - Préparations à base de thé, p. ex. utilisant des additifs
• A23F 3/18 - Extraction des constituants hydrosolubles du thé
• A23P 10/28 - Mise en comprimésFabrication de produits alimentaires en barres par compression d’un mélange pulvérulent sec
• A23P 10/35 - Mise en capsules de particules, p. ex. additifs alimentaires avec des huiles, des lipides, des monoglycérides ou des diglycérides

Produits et services

Nutraceuticals, being botanical extracts, for use as an ingredient in the manufacture of dietary and nutritional supplements

Produits et services

Nutritional supplements, namely, for eye health, comfort and hydration

Produits et services

Plants extracts sold as an ingredient in or component part of nutritional and dietary supplements

Abrégé

The present invention is related to the beta-cryptoxanthin composition comprising beta-cryptoxanthin with one and/or more pharmaceutically/ nutraceutically accepted excipient. More specifically the composition comprises beta-cryptoxanthin either alone or along with at least one carrier oil and antioxidant. The present invention is described the method for the prevention, improvement and/or maintenance of eye health by administering beta-cryptoxanthin compositions in an effective amount to a subject in need thereof. Methods are described herein that is related to prevention, improvement and/or maintenance of pre/age-related macular degeneration, diabetic retinopathy, retinal damage, eye strain & eye fatigue, vitamin A deficiency by administering a composition comprising beta-cryptoxanthin in effective amount either alone or along with at least one pharmaceutically and/or nutraceutically accepted excipient. The Beta-cryptoxanthin compositions described herein reduces retinal stress and inflammation to the subject in need thereof. The compositions herein are safe for human consumption and can be employed for management of overall eye health, when administered in an effective amount to the subject in need thereof.

Classes IPC  ?

• A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
• A61K 31/045 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates
• A61K 8/00 - Cosmétiques ou préparations similaires pour la toilette

Abrégé

The invention relates to a purified xanthophyll composition comprising (trans,R R)-lutein and (trans,R,R)-zeaxanthin, which is comprised of more than 80% of total xanthophylls and a process for the preparation thereof. Purified xanthophyll composition is comprised of selective isomers such as at least 85% by weight of (trans,R,R)-lutein and at least 15% by weight of (trans,R,R)-zeaxanthin. The composition is prepared by process of extraction from two different plant sources using industrially viable process and purified by employing food grade polar and non-polar solvents. The invention relates to purified xanthophyll composition which is selectively free from (R,S)-zeaxanthin and is suitable for human consumption.

Classes IPC  ?

• A61K 36/28 - Asteraceae ou Compositae (famille de l'aster ou du tournesol), p. ex. camomille, chrysanthème matricaire, achillée ou echinacée
• A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol

Produits et services

Plant extracts containing lutein and zeaxanthin sold as an integral component of nutritional supplements for dietary and health applications, not including eye-related or ophthalmic products

Produits et services

Plant extracts containing lutein and zeaxanthin sold as an integral component of nutritional supplements for dietary and health applications, not including eye-related or ophthalmic products

Produits et services

Plant extracts used as ingredients for the manufacture of nutritional supplements.

Produits et services

(1) Plant extracts, other than essential oils, for use in the manufacture of dietary and nutritional supplements for general health and wellbeing

Produits et services

Plant extracts used as ingredients for the manufacture of nutritional supplements

Abrégé

The present invention relates to a stable curcumin composition for prevention improvement and maintenance of arthritis more particularly to osteoarthritis. The stable curcumin composition is comprised of curcuminoids either alone or along with at least one pharmaceutically and/or nutraceutically accepted excipient to form the stable curcumin compositions having enhancement in absorption and bioavailability. The composition is safe for consumption, possess enhanced stability and bioavailability due to selective percentage of amorphous and crystalline polymorphic form of curcumin along with selective excipient such as pH modifier and/or stabilizer and optionally hydrophilic carrier, antioxidant, diluents, anticaking agent, emulsifier, fat and surfactant which result in improvement of symptoms of arthritis and associated conditions, when administered to subjects, in need thereof.

Classes IPC  ?

• A61K 36/9066 - Curcuma, p. ex. curcuma, zédoaire ou curcuma amada
• A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
• A61P 19/02 - Médicaments pour le traitement des troubles du squelette des troubles articulaires, p. ex. arthrites, arthroses

Abrégé

A nutritional composition for prevention, improvement and maintenance of visual function. The nutritional composition comprising the nutrients and at least one pharmaceutically and/or nutraceutically accepted excipient. The nutritional composition wherein the nutrients are selected from one or more of lutein, curcumin and vitamin D3 for prevention, improvement and maintenance of dry eye. The process of preparation of the nutritional composition comprising lutein, curcumin and vitamin D3 use for visual function more specifically dry eye. The present invention is further encompassing to the nutritional composition comprising lutein, curcumin, vitamin D3 in selective percentage which is formulated in different forms like as, powders, granules, pellets, beadlets, caplets, tablets, capsules, soft gel capsules, solution, emulsions, suspensions, oil suspensions, dispersions and the like.

Classes IPC  ?

• A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
• A61K 31/00 - Préparations médicinales contenant des ingrédients actifs organiques

Abrégé

A nutritional composition for prevention, improvement and maintenance of visual function. The nutritional composition comprising the nutrients and at least one pharmaceutically and/or nutraceutically accepted excipient. The nutritional composition wherein the nutrients are selected from one or more of lutein, curcumin and vitamin D3 for prevention, improvement and maintenance of dry eye. The process of preparation of the nutritional composition comprising lutein, curcumin and vitamin D3 use for visual function more specifically dry eye. The present invention is further encompassing to the nutritional composition comprising lutein, curcumin, vitamin D3 in selective percentage which is formulated in different forms like as, powders, granules, pellets, beadlets, caplets, tablets, capsules, soft gel capsules, solution, emulsions, suspensions, oil suspensions, dispersions and the like.

Classes IPC  ?

• A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
• A61K 31/00 - Préparations médicinales contenant des ingrédients actifs organiques

Abrégé

The present invention encompasses an integrated actives selected from one or more of withanolide glycoside enriched ashwagandha, bisdemethoxycurcumin (BDMC) enriched curcumin and acetyl-11-keto-β-boswellic acid (AKBA) enriched boswellia or combination thereof use for prevention, improvement and maintenance of arthritis more specifically for osteoarthritis and joint wellness. Further the present invention is related to process of preparation of the integrated active composition. Further this composition comprises the selective ratio of integrated actives with at least one pharmaceutically and/or nutraceutically accepted excipient.

Classes IPC  ?

• A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
• A61K 36/324 - Boswellia, p. ex. encens
• A61K 36/9066 - Curcuma, p. ex. curcuma, zédoaire ou curcuma amada
• A61P 19/02 - Médicaments pour le traitement des troubles du squelette des troubles articulaires, p. ex. arthrites, arthroses

Produits et services

Nutritional supplements, namely, for eye health, comfort and hydration

Abrégé

The present invention relates to a xanthophyll composition comprising selective isomers of trans-R,R lutein and trans-R,R zeaxanthin in preferred particle size and pharmaceutically and/or nutraceutically acceptable excipients such as carriers, solubility enhancers, bioavailability enhancing agents, antioxidants and optionally flavoring agents with selective ratio which exerts enhanced bioavailability. The xanthophyll composition at least 80% of total xanthophyll comprised of at least 65% by weight of trans-R,R lutein and at least 10 % by weight of trans-R,R zeaxanthin, which is prepared combinedly from marigold and paprika oleoresins with definite proportion to produce the preferred ratio of trans-R,R lutein and trans-R,R zeaxanthin.

Classes IPC  ?

• A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol

Abrégé

The present invention relates to a xanthophyll composition comprising selective isomers of trans-R,R lutein and trans-R,R zeaxanthin in preferred particle size and pharmaceutically and/or nutraceutically acceptable excipients such as carriers, solubility enhancers, bioavailability enhancing agents, antioxidants and optionally flavoring agents with selective ratio which exerts enhanced bioavailability. The xanthophyll composition at least 80% of total xanthophyll comprised of at least 65% by weight of trans-R,R lutein and at least 10 % by weight of trans-R,R zeaxanthin, which is prepared combinedly from marigold and paprika oleoresins with definite proportion to produce the preferred ratio of trans-R,R lutein and trans-R,R zeaxanthin.

Classes IPC  ?

• A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol

Abrégé

The present invention describes pulsed release caffeine formulations comprising caffeine particulate systems prepared by using release retarding agents and at least one or more food grade excipients. The present invention also relates to the process for preparation of caffeine formulations, wherein plurality of particulate systems combined to get the pulsed release caffeine formulation comprising release retarding agents, which provide caffeine release in pulses at different physiological conditions. The pulsed release caffeine formulation is prepared as tablets, capsules, soft gel capsules, caplets, oil suspensions or mixed with nutrient supplements for administration to the subjects. Caffeine formulations as described herein release the caffeine over entire GIT in pulses in a period of 2 to 8 hours and can be administered to subjects for boosting energy, improving concentration, cardiovascular health and for weight management.

Classes IPC  ?

• A61K 9/20 - Pilules, pastilles ou comprimés
• A23F 3/14 - Préparations à base de thé, p. ex. utilisant des additifs
• A23F 3/18 - Extraction des constituants hydrosolubles du thé

Produits et services

Plant extracts containing lutein and zeaxanthin sold as an integral component of nutritional supplements for dietary and health applications, not including eye-related or ophthalmic products

Abrégé

The invention relates to a purified xanthophyll composition comprising (trans,R R)-lutein and (trans,R,R)-zeaxanthin, which is comprised of more than 80% of total xanthophylls and a process for the preparation thereof. Purified xanthophyll composition is comprised of selective isomers such as at least 85% by weight of (trans,R,R)-lutein and at least 15% by weight of (trans,R,R)- zeaxanthin. The composition is prepared by process of extraction from two different plant sources using industrially viable process and purified by employing food grade polar and non-polar solvents. The invention relates to purified xanthophyll composition which is selectively free from (R,S)- zeaxanthin and is suitable for human consumption.

Classes IPC  ?

• C07C 403/24 - Dérivés du cyclohexane ou d'un cyclohexène, comportant une chaîne latérale avec une partie non saturée d'au moins quatre atomes de carbone en ligne, ladite partie étant directement attachée aux cycles cyclohexane ou cyclohexène, p. ex. vitamine A, bêta-carotène, bêta-ionone ayant des chaînes latérales substituées par des cycles non aromatiques à six chaînons, p. ex. bêta-carotène

Abrégé

The invention relates to a purified xanthophyll composition comprising (trans,R R)-lutein and (trans,R,R)-zeaxanthin, which is comprised of more than 80% of total xanthophylls and a process for the preparation thereof. Purified xanthophyll composition is comprised of selective isomers such as at least 85% by weight of (trans,R,R)-lutein and at least 15% by weight of (trans,R,R)- zeaxanthin. The composition is prepared by process of extraction from two different plant sources using industrially viable process and purified by employing food grade polar and non-polar solvents. The invention relates to purified xanthophyll composition which is selectively free from (R,S)- zeaxanthin and is suitable for human consumption.

Classes IPC  ?

• C07C 403/24 - Dérivés du cyclohexane ou d'un cyclohexène, comportant une chaîne latérale avec une partie non saturée d'au moins quatre atomes de carbone en ligne, ladite partie étant directement attachée aux cycles cyclohexane ou cyclohexène, p. ex. vitamine A, bêta-carotène, bêta-ionone ayant des chaînes latérales substituées par des cycles non aromatiques à six chaînons, p. ex. bêta-carotène

Produits et services

Plant extracts containing lutein and zeaxanthin sold as an integral component of nutritional supplements for dietary and health applications, not including eye-related or ophthalmic products

Abrégé

Malassezia furfurMalassezia furfur.

Classes IPC  ?

• A61K 8/31 - Hydrocarbures
• A61K 8/34 - Alcools
• A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
• A61Q 5/00 - Préparations pour les soins des cheveux
• A61Q 5/02 - Préparations pour le lavage des cheveux
• A61Q 17/00 - Préparations protectricesPréparations employées en contact direct avec la peau pour protéger des influences extérieures, p. ex. des rayons du soleil, des rayons X ou d'autres rayons nuisibles, des matériaux corrosifs, des bactéries ou des piqûres d'insectes
• A61K 8/92 - Huiles, graisses ou ciresLeurs dérivés, p. ex. produits d'hydrogénation
• A61K 8/9789 - Magnoliopsida [dicotylédones]

Produits et services

FOOD GRADE EXCIPIENTS, ANTIOXIDANTS, AND PLANTS EXTRACTS USED AS AN INGREDIENT AND COMPONENT PART IN THE MANUFACTURE OF NUTRITIONAL AND DIETARY SUPPLEMENTS

Abrégé

capsicum composition to a physically active subject, wherein body antioxidants are increased and muscle lactates are decreased, resulting in recovery from muscle fatigue arising due to such indoor and/or outdoor physical activities.

Classes IPC  ?

• A61K 31/165 - Amides, p. ex. acides hydroxamiques ayant des cycles aromatiques, p. ex. colchicine, aténolol, progabide
• A61K 36/81 - Solanaceae (famille de la pomme de terre), p. ex. tabac, Solanum ptycanthum, tomate, belladone, poivron ou datura

Produits et services

PLANTS EXTRACTS SOLD AS AN INGREDIENT IN OR COMPONENT PART OF NUTRITIONAL AND DIETARY SUPPLEMENTS, MEDICINAL FUNCTIONAL FOODS AND BEVERAGES AND MEDICAL FOODS; NUTRITIONAL SUPPLEMENTS

Abrégé

A stabilized composition of fat soluble nutrient(s) includes a water soluble polymer and at least one nutraceutically acceptable excipient. The composition can be in the form of significantly amorphous aqueous microparticulate mixtures or as a solid beadlet product. A process for preparation of a stabilized composition includes a fat soluble nutrient solubilized in an organic solvent embedded in an aqueous polymer phase by evaporation, so as to obtain an aqueous microparticulate mixture. This mixture is stable, soluble and can be formulated for end use or can be layered on inert core for example to obtain stable beadlet(s) for use in solid dosage forms. Such stabilized aqueous microparticulate and solid beadlet compositions exhibit good solubility and dispersibility. Stabilized compositions of fat soluble nutrients can be prepared using industrially convenient equipment and can be formulated as per requirement for use in health applications.

Classes IPC  ?

• A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
• A23P 10/30 - Mise en capsules de particules, p. ex. additifs alimentaires
• A23L 33/15 - Vitamines
• A23L 33/115 - Acides gras ou leurs dérivésGraisses ou huiles

Produits et services

Plants extracts sold as an ingredient in or component part of nutritional and dietary supplements, medicinal functional foods and beverages and medical foods

Produits et services

(1) Vegetable extracts used as an ingredient in dietary and nutritional supplements for general health and well being.

Produits et services

Plant extracts containing lutein and zeaxanthin sold as an integral component of nutritional supplements for dietary and health applications, not including eye-related or ophthalmic products Food flavorings in the form of plant extracts containing lutein and zeaxanthin and not being essential oils for dietary, nutritional and health food applications, not including eye-related or ophthalmic products

Abrégé

Methods of improving physical performance and endurance include administering a capsicum composition to a subject. More particularly the methods include administration of an effective amount of a capsicum composition including capsaicinoids alone and/or in combination with other nutrients for improvement in performance of physical activities. The methods described include administration of a capsicum composition to a subject undergoing physical activity to deliver daily dose of capsaicinoids in an effective amount. The methods include administering a capsicum composition to a subject in an effective amount to reduce blood lipids and oxidative stress. Methods for enhancing physical endurance and exhaustion time include administering an effective amount of a capsicum composition to a physically active subject, wherein body antioxidants are increased and muscle lactates are decreased, resulting in recovery from muscle fatigue arising due to such indoor and/or outdoor physical activities.

Classes IPC  ?

• A61K 31/165 - Amides, p. ex. acides hydroxamiques ayant des cycles aromatiques, p. ex. colchicine, aténolol, progabide
• A61P 21/06 - Agents anabolisants
• A61K 36/81 - Solanaceae (famille de la pomme de terre), p. ex. tabac, Solanum ptycanthum, tomate, belladone, poivron ou datura

Produits et services

Plant extracts used as an ingredient in or component part of nutritional and dietary supplements, medicinal functional foods and beverages and medical foods.

Abrégé

The methods relate to preventing photoreceptor damage caused by blue light by oral administration of a macular carotenoid composition comprising of lutein and zeaxanthin isomers. The photoreceptor damage is prevented through the upregulation of genes and protein synthesis manifested by an increase in the levels gene expression and proteins synthesis of Gnatl, Rhodopsin, NCAM, Rod arrestin, GAP-43, Nrf2, Ho-1 and decrease in the GFAP, NFkB (oxidative stress markers) in rat eye models exposed to visible blue light for various time periods and simultaneously treated with macular carotenoid compositions comprising of lutein zeaxanthin and their isomers. Methods described herein also relate to treatment of visual stress conditions by administering macular carotenoid compositions for treatment headache, blurred vision, photoreceptor degeneration, oxidative stress, endoplasmic reticulum stress and the like, which are caused due to prolonged exposure to blue light source.

Classes IPC  ?

• A61K 31/05 - Phénols
• A61K 31/11 - Aldéhydes
• A61P 27/02 - Agents ophtalmiques

Abrégé

The invention relates to compositions comprising lipophilic active, effective amount of an absorption augmenting agent and suitable excipients and the process for preparation thereof. More particularly, the fine free flowing powder composition described herein is comprised of effective amount of lipophilic active such as coenzyme Q10, absorption augmenting agent and other suitable excipients which is formulated by emulsification and size reduction. The size reduced emulsion is spray dried to get fine free flowing powder of lipophilic active which may be further filled in sachets or formulated into solid dosage forms or suspended in oil medium. Oil suspension can be encapsulated in soft gel capsules and/or filled in sachets and is useful for treatment of health ailments. Use of salacia as absorption augmenting agent in coenzyme Q10 formulation resulted in more than 2 times enhanced bioavailability in aqueous medium as compared to unformulated coenzyme Q10.

Classes IPC  ?

• A61K 31/00 - Préparations médicinales contenant des ingrédients actifs organiques
• A61K 31/07 - Composés du rétinol, p. ex. vitamine A
• A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
• A61K 36/37 - Celastraceae (famille du bourreau des arbres ou de la camarine), p. ex. tripterygium ou fusain

Produits et services

(1) Food grade antioxidants and plant extracts, namely, curcumin, sold together as a unit with excipients, used as ingredients in or component part of nutritional and dietary supplements

Produits et services

Food grade excipìents, antioxidants, and plant extracts used as an ingredient in or component part of nutritional and dietary supplements.

Abrégé

Curcumin compositions are described for administration to healthy subjects, in need thereof, for improving cardiovascular flow. Curcumin compositions described herein can be administered to a subject in an effective dose of 250 mg to 1000 mg, corresponding to about 50 mg to 200 mg curcuminoids, for improvement of endothelial function and reducing risk of cardiovascular diseases. Compositions herein include curcumin either alone or curcumin along with at least one excipient to enhance absorption. Compositions herein improve endothelial function in healthy subjects having FMD value of 5-7% or higher and who are not diagnosed with cardiovascular disease. Compositions herein also improve cardiovascular endothelial function by reducing vascular resistance and enhancing nitric oxide generation in vascular endothelium. Curcumin compositions herein are safe for consumption, possesses enhanced absorption and can be employed for improvement of endothelial function and cardiovascular flow, when administered in an effective dose to a healthy subject, in need thereof.

Classes IPC  ?

• A61K 31/05 - Phénols
• A61K 31/12 - Cétones
• A61P 9/14 - VasoprotecteursAntihémorroïdauxMédicaments pour le traitement des varicesStabilisateurs capillaires

Abrégé

Xanthophyll compositions and their methods of use are described, where the compositions include macular pigments as lutein and/or zeaxanthin isomers, and where they are administered in an effective amount for skin lightening and/or improving overall skin tone and/or health in a subject in need thereof. Methods for treatment are described for improvement and/or protection of skin from effects of light rays of variable intensity and/or wavelength on skin tone and/or skin health. Methods herein include administering a xanthophyll composition for skin lightening and/or improving skin tone and/or overall skin health, and to block the melanin pathway and formation of melanin in melanocytes. The compositions and their administration exhibit increased Individual Typological Angle and minimum erythemal dose, which results in rapid skin lightening. The compositions improve overall skin tone and/or skin health, when administered in an effective amount by improving hydration, flexibility and/or protecting skin from damaging effects of light radiation.

Classes IPC  ?

• A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits

Abrégé

The sunscreen composition includes dibenzoylmethane derivative in 1 to 5% by weight of the composition, octyl-methoxycinnamate in 1 to 10% by weight of the composition and dermatologically acceptable excipients in 79 to 97% by weight of the composition containing 60-75% aqueous phase stabilised with 1-(4-methoxy-5-benzofuranyl)-3-phenyl 1, 3 propanedione (pongamol) in 0.9 to 6% by weight of the composition.

Classes IPC  ?

• A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
• A61K 8/27 - ZincSes composés
• A61K 8/29 - TitaneSes composés
• A61K 8/35 - Cétones, p. ex. quinones, benzophénone
• A61K 8/37 - Esters d'acides carboxyliques
• A61K 8/44 - Acides aminocarboxyliques ou leurs dérivés, p. ex. acides aminocarboxyliques contenant du soufreLeurs sels, esters ou dérivés N-acylés
• A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer
• A61K 8/31 - Hydrocarbures
• A61K 8/34 - Alcools
• A61K 8/36 - Acides carboxyliquesLeurs sels ou anhydrides
• A61K 8/41 - Amines
• A61K 8/42 - Amides
• A61K 8/60 - SucresLeurs dérivés
• A61K 8/64 - ProtéinesPeptidesLeurs dérivés ou produits de dégradation
• A61K 8/81 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons insaturées carbone-carbone
• A61K 8/86 - Polyéthers
• A61K 8/891 - Polysiloxanes saturés, p. ex. diméthicone, phényl triméthicone, C24-C28 méthicone, stéaryl diméthicone
• A61K 8/97 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base d’algues, de champignons, de lichens ou de plantesCosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de leurs dérivés

Produits et services

(1) Plant extracts containing lutein and zeaxanthin sold as an integral component of nutritional supplements and dietary supplements for general health and well-being, excluding eye-related or ophthalmic products (2) Food flavorings in the form of plant extracts containing lutein and zeaxanthin sold as an integral component of nutritional supplements and dietary supplements for general health and well-being, excluding eye-related or ophthalmic products

Produits et services

Plants extracts used as an ingredient in or component part of nutritional and dietary supplements, functional foods and beverages, and medical foods.

Produits et services

(1) Plant extracts used as an ingredient in or component part of nutritional and dietary supplements, medicinal functional foods and beverages and medical foods for general health and well-being

Produits et services

(1) Plants extracts used as an ingredient in or component part of nutritional and dietary supplements, functional foods and beverages and medical foods for general health and well-being

Abrégé

Capsicum compositions are described that include biologically active constituents non- capsaicinoids and capsaicinoids in a specific ratio are useful for the treatment and management of cardiometabolic syndrome and associated risk factors, in a subject in need thereof. The capsicum compositions include a capsicum extract which is prepared by extracting capsicum pods by using suitable polar and non-polar solvents. Capsicum compositions include non- capsaicinoid components like saponins and polyphenols such as flavonoids, which along with capsaicinoids effectively reduce risk factors of cardiometabolic syndrome and also reduce oxidative stress on vital body organs by reducing inflammatory and/or oxidative markers. The capsicum compositions inhibit pancreatic lipase enzyme and enhance lipolysis, when administered in an effective amount to a subject in need thereof. Capsicum compositions as described herein are prepared by human intervention and are safe for consumption.

Classes IPC  ?

• A61K 36/81 - Solanaceae (famille de la pomme de terre), p. ex. tabac, Solanum ptycanthum, tomate, belladone, poivron ou datura

Abrégé

Compositions are described that include a betacryptoxanthin extract, rich in trans-betacryptoxanthin, which are prepared by a cost and time effective process and are for use in methods of enhancing cardio-respiratory fitness for physical performance and exercise endurance and to maintain healthy lung function. Betacryptoxanthin extract is prepared by a cost and time effective process of saponification and column chromatography, in which saponification cycle time, solvent amount, column separation time and silica amount are reduced, thus making it industrially viable. Betacryptoxanthin compositions increase exercise time, endurance performance, and lung capacity and maintain healthy lung and cardiovascular function during such physical activities. The compositions also improve physical performance, attenuate muscle fatigue, and enhance aerobic respiration utilization capacity. The compositions are safe for consumption, and can be employed for enhancing cardio-respiratory fitness when administered in an effective amount.

Classes IPC  ?

• A01N 43/04 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés hétérocycliques comportant des cycles avec un ou plusieurs atomes d'oxygène ou de soufre comme uniques hétéro-atomes du cycle avec un hétéro-atome
• A01N 37/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés organiques comportant un atome de carbone possédant trois liaisons à des hétéro-atomes, avec au plus deux liaisons à un halogène, p. ex. acides carboxyliques

Abrégé

Capsicum compositions as described herein are prepared by human intervention and are safe for consumption.

Classes IPC  ?

• A61K 36/81 - Solanaceae (famille de la pomme de terre), p. ex. tabac, Solanum ptycanthum, tomate, belladone, poivron ou datura
• A61K 31/165 - Amides, p. ex. acides hydroxamiques ayant des cycles aromatiques, p. ex. colchicine, aténolol, progabide
• A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
• A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur

Abrégé

Beta-cryptoxanthin compositions and methods are described for the management of cardiometabolic syndrome and associated risk factors, in a subject, in need thereof. Methods herein are directed to identifying such subject at risk of developing cardiometabolic syndrome and administering beta-cryptoxanthin composition to assess the condition of an organ. Compositions and methods herein can effectively reduce risk factors of cardiometabolic syndrome, such as hyperlipidemia, insulin resistance, obesity, diabetes, atherosclerosis and/or related cardiovascular disorders. Beta-cryptoxanthin compositions and methods herein can reduce body weight, body fat, glucose levels, and free fatty acids, when administered in effective amounts. The compositions and methods herein can also reduce oxidative stress on organs such as the eye and liver and/or reduce inflammatory and/or oxidative markers, when administered to subjects in need thereof.

Classes IPC  ?

• A61K 31/07 - Composés du rétinol, p. ex. vitamine A
• A61K 31/045 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates

Abrégé

Methods herein are described for improvement in visual function by administering macular carotenoid compositions containing an effective daily dose, to a subject in need thereof. More particularly, methods herein are described and include use of the compositions herein by identifying a subject in need thereof, administering a daily dose of lutein and/or zeaxanthin isomers, comprised of meso-zeaxanthin and R,R zeaxanthin, alone or in combination thereof, the composition also including at least one food grade excipient, and evaluating visual performance. The subject is exposed to light of variable wavelengths and intensity and is suffering from visual fatigue. The composition improves contrast sensitivity, glare performance, photo stress recovery, and/or macular pigment optical density, and thus alleviates visual fatigue. The composition is safe for human and other animals for consumption and can be used for improvement in visual health in the subject, when administered in an effective amount.

Classes IPC  ?

• A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol

Abrégé

Methods herein are described for improvement in visual function by administering macular carotenoid compositions containing an effective daily dose, to a subject in need thereof. More particularly, methods herein are described and include use of the compositions herein by identifying a subject in need thereof, administering a daily dose of lutein and/or zeaxanthin isomers, comprised of meso-zeaxanthin and R,R zeaxanthin, alone or in combination thereof, the composition also including at least one food grade excipient, and evaluating visual performance. The subject is exposed to light of variable wavelengths and intensity and is suffering from visual fatigue. The composition improves contrast sensitivity, glare performance, photo stress recovery, and/or macular pigment optical density, and thus alleviates visual fatigue. The composition is safe for human and other animals for consumption and can be used for improvement in visual health in the subject, when administered in an effective amount.

Classes IPC  ?

• A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
• A61K 31/07 - Composés du rétinol, p. ex. vitamine A
• A61P 27/00 - Médicaments pour traiter les troubles des sens
• A61P 27/02 - Agents ophtalmiques
• C07C 403/00 - Dérivés du cyclohexane ou d'un cyclohexène, comportant une chaîne latérale avec une partie non saturée d'au moins quatre atomes de carbone en ligne, ladite partie étant directement attachée aux cycles cyclohexane ou cyclohexène, p. ex. vitamine A, bêta-carotène, bêta-ionone

Abrégé

A method for protection, treatment and improvement of liver health includes administering a meso-zeaxanthin composition in an effective amount to a subject in need thereof. In particular, methods are described of administering a meso-zexanthin composition to a subject fed with high fat diet (HFD), and studying the effect of meso-zeaxanthin for treatment of fatty liver condition, through evaluation of various parameters such as biochemical indicators, anti-inflammatory markers, and nutritional markers.

Classes IPC  ?

• A61K 31/045 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates
• A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
• A61K 38/44 - Oxydoréductases (1)

Abrégé

Carotenoid compositions are described for management, treatment, and/or prevention of stress by reducing cortisol levels and/or improving distribution and/or density of macular pigment and thus improving overall health status. More particularly, a subject in need thereof for the method has disturbed macular pigment optical density or increased levels of cortisol as markers of psychological and physiological stress. Methods are also described of administering macular carotenoid compositions in daily doses of at least or about 0.005mg/kg body weight of lutein, and at least or about 0.001mg/kg body weight of meso-zeaxanthin and zeaxanthin isomer along with at least one food grade excipient and evaluating overall health status. The composition may be derived from plant extract containing xanthophylls and/or xanthophylls esters. The composition also reduces cortisol levels in the blood and relieves physiological stress, thus improving overall health status of a subject in need thereof.

Classes IPC  ?

• A61K 31/07 - Composés du rétinol, p. ex. vitamine A
• A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol
• A61K 35/00 - Préparations médicinales contenant des substances ou leurs produits de réaction de constitution non déterminée
• A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
• A61P 27/00 - Médicaments pour traiter les troubles des sens
• C07C 35/21 - Composés comportant au moins un groupe hydroxyle ou O-métal lié à un atome de carbone d'un cycle autre qu'un cycle aromatique à six chaînons polycycliques, avec au moins un groupe hydroxyle lié à un cycle non condensé

Abrégé

Carotenoid compositions are described for management, treatment, and/or prevention of stress by reducing cortisol levels and/or improving distribution and/or density of macular pigment and thus improving overall health status. More particularly, a subject in need thereof for the method has disturbed macular pigment optical density or increased levels of cortisol as markers of psychological and physiological stress. Methods are also described of administering macular carotenoid compositions in daily doses of at least or about 0.005 mg/kg body weight of lutein, and at least or about 0.001 mg/kg body weight of meso-zeaxanthin and zeaxanthin isomer along with at least one food grade excipient and evaluating overall health status. The composition may be derived from plant extract containing xanthophylls and/or xanthophylls esters. The composition also reduces cortisol levels in the blood and relieves physiological stress, thus improving overall health status of a subject in need thereof.

Classes IPC  ?

• A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol
• A61K 31/07 - Composés du rétinol, p. ex. vitamine A
• A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
• A61P 27/00 - Médicaments pour traiter les troubles des sens
• G01N 33/74 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des hormones
• G01N 33/487 - Analyse physique de matériau biologique de matériau biologique liquide
• G01N 30/00 - Recherche ou analyse de matériaux par séparation en constituants utilisant l'adsorption, l'absorption ou des phénomènes similaires ou utilisant l'échange d'ions, p. ex. la chromatographie
• G01N 21/59 - Transmissivité
• G01N 30/88 - Systèmes intégrés d'analyse, spécialement adaptés à cet effet, non couverts par un seul des groupes

Abrégé

A method for protection, treatment and improvement of liver health includes administering a meso-zeaxanthin composition in an effective amount to a subject in need thereof. In particular, methods are described of administering a meso-zexanthin composition to a subject fed with high fat diet (HFD), and studying the effect of meso-zeaxanthin for treatment of fatty liver condition, through evaluation of various parameters such as biochemical indicators, anti-inflammatory markers, and nutritional markers.

Classes IPC  ?

• A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol

Produits et services

Plants extracts, namely mustard oil extract sold as an ingredient in or component part of nutritional and dietary supplements, medicinal functional foods and beverages and medical foods; nutritional supplements.

Abrégé

Stable oil suspensions are described that have enhanced bioavailability and contain lipophilic nutrients uniformly dispersed in a solid hydrophilic carrier and suspended in an oil medium. A process for preparation of stable oil suspensions of lipophilic nutrients and compositions of these suspensions such as soft gelatin capsules are also described. The oil suspensions include soluble granules of lipophilic nutrients suspended in oil. Soluble granules include lipophilic nutrients dispersed uniformly in a solid hydrophilic carrier with one or more food grade excipient. Stable oil suspensions of the invention include at least 1% to about 50% lipophilic nutrient. These oil suspensions are resistant to oxidation and exhibit enhanced stability and bioavailability as compared to soluble granules and to marketed comparative products. Oil suspensions herein can be encapsulated in soft gel capsules or filled in sachets to administer conveniently to patients.

Classes IPC  ?

• A23L 1/00 - Aliments ou produits alimentaires; Leur préparation ou traitement (leur conservation en général A23L 3/00)
• A23L 1/30 - contenant des additifs (A23L 1/308 a priorité);;
• A23L 1/302 - Vitamines
• A23L 1/303 - Vitamines A ou D
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/51 - Nanocapsules
• A61K 36/28 - Asteraceae ou Compositae (famille de l'aster ou du tournesol), p. ex. camomille, chrysanthème matricaire, achillée ou echinacée

Abrégé

The present invention provides use of composition containing molecular dispersions of carotenoids for the prevention of neurodegenerative disorders which are safe for human consumption and are particularly useful as dietary supplements for nutrition and health promoting benefits. The present invention particularly relates to the use of highly water soluble composition with enhanced bioavailability containing at least 80% by weight of total xanthophylls, out of which the trans-lutein content is 80-95% w/w; (R,R)-zeaxanthin is 14-20% w/w; (R,S)-zeaxanthin is 0.01-1% w/w and traces of other carotenoids derived from the plant extracts/oleoresin containing xanthophylls/xanthophylls esters. The present invention also provides use of the said composition in treatment of neurodegenerative disorders when co-administered along with reduced dose of Levodopa and Carbidopa.

Classes IPC  ?

• A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol
• A61K 31/07 - Composés du rétinol, p. ex. vitamine A
• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]

Abrégé

capsicum fruits. The production of beta-cryptoxanthin crystals with high content of trans-beta-cryptoxanthin makes it ideal and suitable for use as a provitamin A source material and also has potential effects on improving bone health and inhibiting bone resorption.

Classes IPC  ?

• A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
• C07C 403/02 - Dérivés du cyclohexane ou d'un cyclohexène, comportant une chaîne latérale avec une partie non saturée d'au moins quatre atomes de carbone en ligne, ladite partie étant directement attachée aux cycles cyclohexane ou cyclohexène, p. ex. vitamine A, bêta-carotène, bêta-ionone ayant des chaînes latérales contenant uniquement des atomes de carbone et d'hydrogène
• A61K 31/045 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates
• C07C 403/24 - Dérivés du cyclohexane ou d'un cyclohexène, comportant une chaîne latérale avec une partie non saturée d'au moins quatre atomes de carbone en ligne, ladite partie étant directement attachée aux cycles cyclohexane ou cyclohexène, p. ex. vitamine A, bêta-carotène, bêta-ionone ayant des chaînes latérales substituées par des cycles non aromatiques à six chaînons, p. ex. bêta-carotène
• C09B 61/00 - Colorants naturels préparés à partir de sources naturelles
• B01D 15/42 - Adsorption sélective, p. ex. chromatographie caractérisée par le mode de développement, p. ex. par déplacement ou par élution
• A23L 5/44 - Adjonction de colorants ou de pigments, p. ex. en combinaison avec des azurants optiques en utilisant des colorants ou des pigments organiques d'origine naturelle, leurs doublons artificiels ou leurs dérivés en utilisant des caroténoïdes ou des xanthophylles
• A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés

Abrégé

The instant invention provides hydrophilic matrix beadlet compositions that include at least one fat soluble nutrient and an effective amount of cellulose polymer with low viscosity. The invention also provides a process for the preparation of the hydrophilic matrix composition by employing a fluid bed system or extrusion spheronization technique. This hydrophilic matrix beadlet composition is comprised of at least 5% to about 25% carotenoid wherein free lutein is present in combination with zeaxanthin. The free flowing nature of the composition allows it to be compressed into tablets or to be filled into two piece capsules or blended as a dry premix for beverage applications. These hydrophilic matrix compositions exhibit desired dissolution characteristics and at least 1.6 times more bioavailability as compared with marketed reference formulations containing modified starch, thus making it advantageous for nutraceutical applications.

Classes IPC  ?

• A61K 9/50 - Microcapsules
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol
• A23L 1/00 - Aliments ou produits alimentaires; Leur préparation ou traitement (leur conservation en général A23L 3/00)
• A23L 1/30 - contenant des additifs (A23L 1/308 a priorité);;
• A23L 1/302 - Vitamines

Abrégé

The instant invention provides hydrophilic matrix beadlet compositions that include at least one fat soluble nutrient and an effective amount of cellulose polymer with low viscosity. The invention also provides a process for the preparation of the hydrophilic matrix composition by employing a fluid bed system or extrusion spheronization technique. This hydrophilic matrix beadlet composition is comprised of at least 5% to about 25% carotenoid wherein free lutein is present in combination with zeaxanthin. The free flowing nature of the composition allows it to be compressed into tablets or to be filled into two piece capsules or blended as a dry premix for beverage applications. These hydrophilic matrix compositions exhibit desired dissolution characteristics and at least 1.6 times more bioavailability as compared with marketed reference formulations containing modified starch, thus making it advantageous for nutraceutical applications.

Classes IPC  ?

• A23L 1/30 - contenant des additifs (A23L 1/308 a priorité);;
• A23L 1/302 - Vitamines
• A23L 1/00 - Aliments ou produits alimentaires; Leur préparation ou traitement (leur conservation en général A23L 3/00)
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres

Abrégé

Curcumin compositions herein are described for improving muscle performance, endurance capacity and resistance to fatigue, when administered in effective amounts to a subject in need of such improvement. The compositions are comprised of curcumin and at least one pharmaceutically and/or nutraceutically acceptable excipient such as a hydrophilic carrier and exhibit enhanced bioavailability. More particularly methods are described and include use of curcumin compositions to increase exercise time, performance and capacity and to prevent muscle soreness, fatigue and injury. The compositions enhance mitochondrial biogenesis by modulating mitochondrial function, increasing mitochondrial mass and oxygen consumption, thus increasing mitochondrial aerobic capacity. The compositions reduce oxidative muscle stress, by decreasing inflammatory cytokines and inflammatory markers. Curcumin compositions are safe for consumption for pharmaceutical and/or nutraceutical purposes and are prepared by economic methods using conventional equipments and can be effectively used for enhancing muscle and exercise performance.

Classes IPC  ?

• A61K 31/12 - Cétones
• A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés

Abrégé

Curcumin compositions herein are described for improving muscle performance, endurance capacity and resistance to fatigue, when administered in effective amounts to a subject in need of such improvement. The compositions are comprised of curcumin and at least one pharmaceutically and/or nutraceutically acceptable excipient such as a hydrophilic carrier and exhibit enhanced bioavailability. More particularly methods are described and include use of curcumin compositions to increase exercise time, performance and capacity and to prevent muscle soreness, fatigue and injury. The compositions enhance mitochondrial biogenesis by modulating mitochondrial function, increasing mitochondrial mass and oxygen consumption, thus increasing mitochondrial aerobic capacity. The compositions reduce oxidative muscle stress, by decreasing inflammatory cytokines and inflammatory markers. Curcumin compositions are safe for consumption for pharmaceutical and/or nutraceutical purposes and are prepared by economic methods using conventional equipments and can be effectively used for enhancing muscle and exercise performance.

Classes IPC  ?

• A61P 39/06 - Antiradicaux libres ou antioxydants
• A61K 36/9066 - Curcuma, p. ex. curcuma, zédoaire ou curcuma amada
• A61K 31/12 - Cétones
• A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique

Abrégé

Compositions containing molecular dispersions of lipophilic nutrients and methods thereof are provided for delaying the development and maturation of eye related complications of diabetes by administering a composition containing lipophilic nutrients. More particularly, methods relate to delaying the development and maturation of eye related complications of diabetes by administering a composition containing lutein and its isomers, lutein ester, zeaxanthin isomers, turmeric extract, curcumin or curcuminoids, derived from plant extract/oleoresin containing xanthophylls/xanthophylls esters which are safe for human consumption and are particularly useful as dietary supplements for nutrition and health promoting benefits.

Classes IPC  ?

• A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol
• A61K 36/9066 - Curcuma, p. ex. curcuma, zédoaire ou curcuma amada
• A61K 36/9068 - Zingiber, p. ex. gingembre
• A61K 47/00 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif
• A61K 31/09 - Éthers ou acétals ayant une liaison éther à un carbone cyclique d'un noyau aromatique ayant plusieurs liaisons éther
• A61P 27/12 - Agents ophtalmiques pour le traitement de la cataracte
• A61P 27/02 - Agents ophtalmiques
• A23L 1/30 - contenant des additifs (A23L 1/308 a priorité);;

Abrégé

The sunscreen composition includes dibenzoylmethane derivative in 1 to 5% by weight of the composition, octyl-methoxycinnamate in 1 to 10% by weight of the composition and dermatologically acceptable excipients in 79 to 97% by weight of the composition containing 60 - 75% aqueous phase stabilised with 1-(4-methoxy-5-benzofuranyl)-3 -phenyl 1, 3 propanedione (pongamol) in 0.9 to 6% by weight of the composition.

Classes IPC  ?

• A61K 8/35 - Cétones, p. ex. quinones, benzophénone

Produits et services

(1) Providing information in the field of eye health.

Produits et services

Providing information in the field of eye health.

Abrégé

A composition of oily, pungent and odoriferous substances and a process for preparation thereof are described, in particular an extended and sustained release of a stable, free flowing, solid composition of one or more of substances such as capsicum, black pepper, ginger, mustard, cinnamon, garlic, onion, paprika, turmeric and the like, extracts thereof, and/or components thereof, and a process for preparation thereof are described. For example, compositions comprise a substance such as capsicum containing capsaicinoid components, which include for example capsaicin, dihydro-capsaicin, and/or nor-dihydro-capsaicin.The composition can eliminate the discomfort by facilitating intestinal absorption of the active ingredient and thereby minimizing/eliminating the discomfort caused by the residual unabsorbed active ingredient, and can be particularly suitable for formulating into consumable dry syrups, tablets, capsules, liquid syrups, health drinks, diet drinks, fruit juices, and/or soft drinks, which can be useful in reduction of body weight.

Classes IPC  ?

• A23L 1/22 - Epices; Agents aromatiques ou condiments; Edulcorants artificiels; Sels de table; Substituts diététiques du sel
• A23L 1/221 - Epices, agents aromatiques ou condiments naturels; Leurs extraits
• A23L 1/225 - Moutarde
• A61K 36/81 - Solanaceae (famille de la pomme de terre), p. ex. tabac, Solanum ptycanthum, tomate, belladone, poivron ou datura
• A61K 31/165 - Amides, p. ex. acides hydroxamiques ayant des cycles aromatiques, p. ex. colchicine, aténolol, progabide
• A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
• A61P 3/04 - AnorexigènesMédicaments de l'obésité

Produits et services

Plants extracts used as an ingredient in or component part of nutritional and dietary supplements, functional foods and beverages and medical foods.

Produits et services

Plants extracts used as an ingredient in or component part of nutritional and dietary supplements, functional foods and beverages and medical foods.

Abrégé

capsicum containing capsaicinoid components, which include for example capsaicin, dihydro-capsaicin, and/or nor-dihydro-capsaicin. The composition can eliminate the discomfort by facilitating intestinal absorption of the active ingredient and thereby minimizing/eliminating the discomfort caused by the residual unabsorbed active ingredient, and can be particularly suitable for formulating into consumable dry syrups, tablets, capsules, liquid syrups, health drinks, diet drinks, fruit juices, and/or soft drinks, which can be useful in reduction of body weight.

Classes IPC  ?

• A61K 36/81 - Solanaceae (famille de la pomme de terre), p. ex. tabac, Solanum ptycanthum, tomate, belladone, poivron ou datura
• A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
• A23L 5/00 - Préparation ou traitement des aliments ou produits alimentaires en généralAliments ou produits alimentaires ainsi obtenusLeurs matériaux
• A61K 31/165 - Amides, p. ex. acides hydroxamiques ayant des cycles aromatiques, p. ex. colchicine, aténolol, progabide
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A23L 2/56 - Agents aromatiques ou amers
• A23L 2/58 - Agents colorants
• A23P 10/30 - Mise en capsules de particules, p. ex. additifs alimentaires
• A23L 27/00 - ÉpicesAgents aromatiques ou condimentsÉdulcorants artificielsSels de tableSubstituts diététiques du selLeur préparation ou leur traitement
• A23L 27/10 - Épices, agents aromatiques ou condiments naturelsLeurs extraits
• A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
• A23L 29/30 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des sirops d'hydrate de carboneAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des sucresAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des alcools de sucre, p. ex. du xylitolAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des hydrolysats d'amidon, p. ex. de la dextrine
• A23L 29/262 - CelluloseSes dérivés, p. ex. éthers
• A23L 27/18 - Moutarde
• A23L 27/16 - Oignons

Abrégé

Salacia compositions herein reduce appetite by about 18% of routine diet, when effective amounts are administered to a subject in need thereof. Effective management of a healthy lipid profile is thus possible with synergistic combination of reduction in energy intake, activation of Hormone Sensitive Lipase, and inhibition of HMG-CoA Reductase enzyme responsible for cholesterol metabolism.

Classes IPC  ?

• A61K 36/37 - Celastraceae (famille du bourreau des arbres ou de la camarine), p. ex. tripterygium ou fusain
• A61K 31/122 - Cétones ayant l'atome d'oxygène lié directement à un cycle, p. ex. quinones, vitamine K1, anthraline
• A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
• A61K 31/7048 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'oxygène comme hétéro-atome d'un cycle, p. ex. leucoglucosane, hespéridine, érythromycine, nystatine
• A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
• A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés

Produits et services

Plant extracts containing lutein and zeaxanthin sold as an integral component of nutritional supplements for dietary and health applications, not including eye-related or ophthalmic products. Food flavorings in the form of plant extracts containing lutein and zeaxanthin and not being essential oils for dietary, nutritional and health food applications, not including eye-related or ophthalmic products.

Produits et services

Plant extracts sold as an integral component of nutritional supplements for dietary and health applications, not including eye-related or ophthalmic products. Food flavorings in the form of plant extracts and not being essential oils for dietary, nutritional and health food applications, not including eye-related or ophthalmic products.

Produits et services

Plant extracts sold as an integral component of nutritional supplements for dietary and health applications, not including eye-related or ophthalmic products. Food flavorings in the form of plant extracts and not being essential oils for dietary, nutritional and health food applications, not including eye-related or ophthalmic products.

Produits et services

Food grade excipients, antioxidants, and plants extracts used ingredient in or component part of nutritional and dietary supplements

Produits et services

Food grade excipients, antioxidants, and plants extracts used ingredient in or component part of nutritional and dietary supplements

Produits et services

Plant extracts, namely, ginger extracts used as a component ingredient for nutritional and dietary supplements

Abrégé

The present invention provides use of composition containing molecular dispersions - of carotenoids for the prevention of neurodegenerative disorders which are safe for human consumption and are particularly useful as dietary supplements for nutrition and health promoting benefits. The present invention particularly relates to the use of highly water soluble composition with enhanced bioavailability containing at least 80% by weight of total xanthophylls, out of which the trans-lutein content is 80-95% w/w; (R,R)-zeaxanthin is 14-20% w/w; (R,S)-zeaxanthin is 0.01-1%) w/w and traces of other carotenoids derived from the plant extracts/oleoresin containing xanthophylls/xanthophylls esters. The present invention also provides use of the said composition in treatment of neurodegenerative disorders when co-administered along with reduced dose of Levodopa and Carbidopa.

Classes IPC  ?

• A61K 31/07 - Composés du rétinol, p. ex. vitamine A
• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]

Abrégé

The present invention provides beta-cryptoxanthin crystals from plant source and a process for its preparation. The present invention particularly relates to a process for the preparation of high purity beta-cryptoxanthin crystals comprising at least about 10% by weight total xanthophylls, of which at least about 75% by weight is trans-beta-cryptoxanthin and the remaining including beta-carotene, and trace amounts of trans-capsanthin and other carotenoids derived from the plant source, including capsicum fruits. The production of beta-cryptoxanthin crystals with high content of trans-beta-cryptoxanthin makes it ideal and suitable for use as a provitamin A source material and also has potential effects on improving bone health and inhibiting bone resorption.

Classes IPC  ?

• G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer

Produits et services

(1) Plant extracts containing lutein and zeaxanthin sold as an integral component of nutritional supplements and dietary supplements for general health and well-being, not including eye-related or ophthalmic products; flavorings in the form of plant extracts containing lutein and zeaxanthin and not being essential oils for dietary, nutritional and health food applications, not including eye-related or ophthalmic products.

Produits et services

Plant extracts containing lutein and zeaxanthin sold as an integral component of nutritional supplements for dietary and health applications, not including eye-related or ophthalmic products Flavorings in the form of plant extracts containing lutein and zeaxanthin and not being essential oils for dietary, nutritional and health food applications, not including eye-related or ophthalmic products

Produits et services

(1) Omega 3 fatty acids and plant extracts, namely, lutein extracts for use as an ingredient in the manufacture of dietary and nutritional supplements.

Produits et services

(1) Plant extract used as a component ingredient of dietary supplements and nutritional supplements for general health and well-being; nutritional and dietary supplements for general health and well-being.

Produits et services

Plant extracts used as ingredients for nutritional supplements for dietary and health applications; nutritional and dietary supplements.

Produits et services

Plant extract used as a component ingredient of dietary supplements and nutritional supplements; Nutritional and dietary supplements